Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management.
Vivek P ChavdaAayushi B PatelLalitkumar K VoraVasso ApostolopoulosBruce D UhalPublished in: Expert review of vaccines (2022)
With existing knowledge of the virus, and the nature of DC, DC-based vaccines may be proven to be effective in inducing long-lasting protective immunity, especially T cell responses.